{"id": "article-30327_0", "title": "Deadly Single Dose Agents -- Continuing Education Activity", "content": "Although the basics of evaluating and treating most unknown ingestants are well known, many overdoses require very specific treatment if the patient is to have any chance of survival. Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur. In the United States, poison control centers receive over 2.2 million calls each year, 47% of which concern children less than six years of age. Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications. Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics. This activity reviews the deadly single dose toxic agents and discusses the interprofessional team's role in educating families on protecting children from exposure to these agents.", "contents": "Deadly Single Dose Agents -- Continuing Education Activity. Although the basics of evaluating and treating most unknown ingestants are well known, many overdoses require very specific treatment if the patient is to have any chance of survival. Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur. In the United States, poison control centers receive over 2.2 million calls each year, 47% of which concern children less than six years of age. Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications. Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics. This activity reviews the deadly single dose toxic agents and discusses the interprofessional team's role in educating families on protecting children from exposure to these agents."}
{"id": "article-30327_1", "title": "Deadly Single Dose Agents -- Continuing Education Activity", "content": "Objectives: Outline the challenges of public education in regard to preventing overdoses. Identify the common causes of pediatric and adult overdoses. Describe the common interventions for single-dose agent overdoses. Review the interprofessional team's role in educating families on protecting children from exposure to these deadly single-dose toxic agents. Access free multiple choice questions on this topic.", "contents": "Deadly Single Dose Agents -- Continuing Education Activity. Objectives: Outline the challenges of public education in regard to preventing overdoses. Identify the common causes of pediatric and adult overdoses. Describe the common interventions for single-dose agent overdoses. Review the interprofessional team's role in educating families on protecting children from exposure to these deadly single-dose toxic agents. Access free multiple choice questions on this topic."}
{"id": "article-30327_2", "title": "Deadly Single Dose Agents -- Introduction", "content": "Although the basics of evaluating and treating most unknown ingestants\u00a0are\u00a0well known, many overdoses require very specific treatment if the patient is to have any chance of survival. [1] Countless studies have been published supporting Dr. Gideon Koren's 1993 landmark article \"Medications Which Can Kill a Toddler with One Tablet or Teaspoonful\" in the Journal of Toxicology. [2] [3] [4] [5] while each has its own merits, most focus solely on pediatric overdoses, and relatively few of them provide an exhaustive list or act as a \"quick-reference\" when dealing with real-time ingestions.", "contents": "Deadly Single Dose Agents -- Introduction. Although the basics of evaluating and treating most unknown ingestants\u00a0are\u00a0well known, many overdoses require very specific treatment if the patient is to have any chance of survival. [1] Countless studies have been published supporting Dr. Gideon Koren's 1993 landmark article \"Medications Which Can Kill a Toddler with One Tablet or Teaspoonful\" in the Journal of Toxicology. [2] [3] [4] [5] while each has its own merits, most focus solely on pediatric overdoses, and relatively few of them provide an exhaustive list or act as a \"quick-reference\" when dealing with real-time ingestions."}
{"id": "article-30327_3", "title": "Deadly Single Dose Agents -- Introduction", "content": "Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur.\u00a0 In the United States, poison control centers receive over 2.2 million calls each year, 47% of\u00a0which\u00a0concern children less than six years of age.\u00a0 Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications.\u00a0 Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics. Following are the list of toxic drugs (in decreasing severity/difficulty of treatment) included in this summary:", "contents": "Deadly Single Dose Agents -- Introduction. Despite widespread public education, childproof containers, and other safety measures, accidental overdoses continue to occur.\u00a0 In the United States, poison control centers receive over 2.2 million calls each year, 47% of\u00a0which\u00a0concern children less than six years of age.\u00a0 Most pediatric accidental ingestions involve cosmetics and personal care products, followed by cleaning products, and then analgesics and prescription medications.\u00a0 Adult overdoses usually are due to the intentional ingestion of analgesics and sedative-hypnotics. Following are the list of toxic drugs (in decreasing severity/difficulty of treatment) included in this summary:"}
{"id": "article-30327_4", "title": "Deadly Single Dose Agents -- Introduction", "content": "Alpha-2 adrenergic agonists - clonidine, naphazoline, oxymetazoline, tetrahydrozoline", "contents": "Deadly Single Dose Agents -- Introduction. Alpha-2 adrenergic agonists - clonidine, naphazoline, oxymetazoline, tetrahydrozoline"}
{"id": "article-30327_5", "title": "Deadly Single Dose Agents -- Introduction", "content": "Sulfonylureas - chlorpropamide, glyburide, glipizide, glimepiride", "contents": "Deadly Single Dose Agents -- Introduction. Sulfonylureas - chlorpropamide, glyburide, glipizide, glimepiride"}
{"id": "article-30327_6", "title": "Deadly Single Dose Agents -- Introduction", "content": "Calcium channel blockers - nifedipine, verapamil, diltiazem, amlodipine, nicardipine", "contents": "Deadly Single Dose Agents -- Introduction. Calcium channel blockers - nifedipine, verapamil, diltiazem, amlodipine, nicardipine"}
{"id": "article-30327_7", "title": "Deadly Single Dose Agents -- Introduction", "content": "Beta-blockers - metoprolol, labetalol", "contents": "Deadly Single Dose Agents -- Introduction. Beta-blockers - metoprolol, labetalol"}
{"id": "article-30327_8", "title": "Deadly Single Dose Agents -- Introduction", "content": "Tricyclic antidepressants - imipramine, desipramine, amitriptyline, nortriptyline", "contents": "Deadly Single Dose Agents -- Introduction. Tricyclic antidepressants - imipramine, desipramine, amitriptyline, nortriptyline"}
{"id": "article-30327_9", "title": "Deadly Single Dose Agents -- Introduction", "content": "Opioids - codeine, hydrocodone, methadone, morphine, heroin", "contents": "Deadly Single Dose Agents -- Introduction. Opioids - codeine, hydrocodone, methadone, morphine, heroin"}
{"id": "article-30327_10", "title": "Deadly Single Dose Agents -- Introduction", "content": "Anti-diarrheals - diphenoxylate + atropine, loperamide", "contents": "Deadly Single Dose Agents -- Introduction. Anti-diarrheals - diphenoxylate + atropine, loperamide"}
{"id": "article-30327_11", "title": "Deadly Single Dose Agents -- Introduction", "content": "Salicylates/Methyl salicylates - wintergreen oil, bismuth subsalicylate, mentholated balms", "contents": "Deadly Single Dose Agents -- Introduction. Salicylates/Methyl salicylates - wintergreen oil, bismuth subsalicylate, mentholated balms"}
{"id": "article-30327_12", "title": "Deadly Single Dose Agents -- Introduction", "content": "Antipsychotics - loxapine, thioridazine, chlorpromazine", "contents": "Deadly Single Dose Agents -- Introduction. Antipsychotics - loxapine, thioridazine, chlorpromazine"}
{"id": "article-30327_13", "title": "Deadly Single Dose Agents -- Introduction", "content": "Antimalarials - chloroquine, hydroxychloroquine, quinine", "contents": "Deadly Single Dose Agents -- Introduction. Antimalarials - chloroquine, hydroxychloroquine, quinine"}
{"id": "article-30327_14", "title": "Deadly Single Dose Agents -- Introduction", "content": "Antiarrhythmics - quinidine, disopyramide, procainamide, flecainide", "contents": "Deadly Single Dose Agents -- Introduction. Antiarrhythmics - quinidine, disopyramide, procainamide, flecainide"}
{"id": "article-30327_15", "title": "Deadly Single Dose Agents -- Introduction", "content": "Terpenoid (camphor) - analgesic, anti-itch, and cooling gels, ointments, and balms", "contents": "Deadly Single Dose Agents -- Introduction. Terpenoid (camphor) - analgesic, anti-itch, and cooling gels, ointments, and balms"}
{"id": "article-30327_16", "title": "Deadly Single Dose Agents -- Introduction", "content": "Non-alkaloid toxic lignan - podophyllin, podofilox", "contents": "Deadly Single Dose Agents -- Introduction. Non-alkaloid toxic lignan - podophyllin, podofilox"}
{"id": "article-30327_17", "title": "Deadly Single Dose Agents -- Introduction", "content": "Plant toxin/secondary metabolite - colchicine", "contents": "Deadly Single Dose Agents -- Introduction. Plant toxin/secondary metabolite - colchicine"}
{"id": "article-30327_18", "title": "Deadly Single Dose Agents -- Introduction", "content": "Oral acetylcholinesterase inhibitors - rivastigmine, donepezil, galantamine", "contents": "Deadly Single Dose Agents -- Introduction. Oral acetylcholinesterase inhibitors - rivastigmine, donepezil, galantamine"}
{"id": "article-30327_19", "title": "Deadly Single Dose Agents -- Introduction", "content": "Methylxanthine - theophylline: 1,3-dimethylxanthine", "contents": "Deadly Single Dose Agents -- Introduction. Methylxanthine - theophylline: 1,3-dimethylxanthine"}
{"id": "article-30327_20", "title": "Deadly Single Dose Agents -- Introduction", "content": "Partial opioid agonist/synthetics - buprenorphine/fentanyl", "contents": "Deadly Single Dose Agents -- Introduction. Partial opioid agonist/synthetics - buprenorphine/fentanyl"}
{"id": "article-30327_21", "title": "Deadly Single Dose Agents -- Introduction", "content": "Toxic alcohols - methanol, ethylene glycol", "contents": "Deadly Single Dose Agents -- Introduction. Toxic alcohols - methanol, ethylene glycol"}
{"id": "article-30327_22", "title": "Deadly Single Dose Agents -- Introduction", "content": "Caustics /household products - acidic or alkaline household products, hydrofluoric acid, selenious acid, ammonia fluoride, methacrylic acid (cosmetic glue), naphthalene (mothballs)", "contents": "Deadly Single Dose Agents -- Introduction. Caustics /household products - acidic or alkaline household products, hydrofluoric acid, selenious acid, ammonia fluoride, methacrylic acid (cosmetic glue), naphthalene (mothballs)"}
{"id": "article-30327_23", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Alpha-2 adrenergic agonists: alpha-2 receptors mediate the transmission of neurotransmitters (acetylcholine & norepinephrine) across the synapse, effectively antagonizing them", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Alpha-2 adrenergic agonists: alpha-2 receptors mediate the transmission of neurotransmitters (acetylcholine & norepinephrine) across the synapse, effectively antagonizing them"}
{"id": "article-30327_24", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Sulfonylureas: stimulates the pancreas to increase insulin production", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Sulfonylureas: stimulates the pancreas to increase insulin production"}
{"id": "article-30327_25", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Calcium channel blockers: decrease cardiac inotropy and increase vasodilation; can also block insulin secretion in the setting of overdose, which can directly affect the heart\u00a0and thereby worsening\u00a0shock", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Calcium channel blockers: decrease cardiac inotropy and increase vasodilation; can also block insulin secretion in the setting of overdose, which can directly affect the heart\u00a0and thereby worsening\u00a0shock"}
{"id": "article-30327_26", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Beta-blockers: direct action on the heart causing bradycardia (less severe in children); blockage of gluconeogenesis leading to hypoglycemia; central nervous system (CNS) depression (crosses blood-brain barrier due to high lipid solubility)", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Beta-blockers: direct action on the heart causing bradycardia (less severe in children); blockage of gluconeogenesis leading to hypoglycemia; central nervous system (CNS) depression (crosses blood-brain barrier due to high lipid solubility)"}
{"id": "article-30327_27", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Tricyclic antidepressants: block fast sodium channels, leading to intraventricular conduction delay; wide QRS and right axis deviation on EKG", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Tricyclic antidepressants: block fast sodium channels, leading to intraventricular conduction delay; wide QRS and right axis deviation on EKG"}
{"id": "article-30327_28", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Opioids: direct suppression of CNS respiratory center leading to hypoxic respiratory failure", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Opioids: direct suppression of CNS respiratory center leading to hypoxic respiratory failure"}
{"id": "article-30327_29", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Anti-diarrheals: biphasic toxicity - first anticholinergic effects and then a longer-lasting opioid effect", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Anti-diarrheals: biphasic toxicity - first anticholinergic effects and then a longer-lasting opioid effect"}
{"id": "article-30327_30", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Salicylates/Methyl salicylates: direct stimulation of CNS respiratory center (respiratory alkalosis) then metabolic acidosis", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Salicylates/Methyl salicylates: direct stimulation of CNS respiratory center (respiratory alkalosis) then metabolic acidosis"}
{"id": "article-30327_31", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Antipsychotics: block post-synaptic dopamine receptors and the reticular activating system (also some serotonin antagonism)", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Antipsychotics: block post-synaptic dopamine receptors and the reticular activating system (also some serotonin antagonism)"}
{"id": "article-30327_32", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Antimalarials: sodium channel blockade; QRS widening", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Antimalarials: sodium channel blockade; QRS widening"}
{"id": "article-30327_33", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Antiarrhythmics: sodium channel blockade; QRS widening", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Antiarrhythmics: sodium channel blockade; QRS widening"}
{"id": "article-30327_34", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Terpenoid (camphor): topical rubefacient induces local hyperemia and warmth", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Terpenoid (camphor): topical rubefacient induces local hyperemia and warmth"}
{"id": "article-30327_35", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Non-alkaloid toxic lignans: interrupt cell mitosis by binding to tubulin and\u00a0disrupting the microtubular network, thereby\u00a0disturbing cellular protein assembly and leading to sepsis and multisystem organ failure", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Non-alkaloid toxic lignans: interrupt cell mitosis by binding to tubulin and\u00a0disrupting the microtubular network, thereby\u00a0disturbing cellular protein assembly and leading to sepsis and multisystem organ failure"}
{"id": "article-30327_36", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Plant toxins/secondary metabolites: same as the lignan. Interrupt cell mitosis by binding to tubulin\u00a0and\u00a0disrupting the microtubular network, thereby\u00a0disturbing cellular protein assembly and leading to sepsis and multisystem organ failure", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Plant toxins/secondary metabolites: same as the lignan. Interrupt cell mitosis by binding to tubulin\u00a0and\u00a0disrupting the microtubular network, thereby\u00a0disturbing cellular protein assembly and leading to sepsis and multisystem organ failure"}
{"id": "article-30327_37", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Oral acetylcholinesterase inhibitors: act on nicotinic and muscarinic receptors; cholinergic toxidrome", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Oral acetylcholinesterase inhibitors: act on nicotinic and muscarinic receptors; cholinergic toxidrome"}
{"id": "article-30327_38", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Methylxanthines: inhibit phosphodiesterase enzymes which increase cAMP and cGMP to cause bronchodilation", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Methylxanthines: inhibit phosphodiesterase enzymes which increase cAMP and cGMP to cause bronchodilation"}
{"id": "article-30327_39", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Partial opioid agonist/synthetics: direct suppression of CNS respiratory center (one lick can be enough to be toxic in a child) [6]", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Partial opioid agonist/synthetics: direct suppression of CNS respiratory center (one lick can be enough to be toxic in a child) [6]"}
{"id": "article-30327_40", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Toxic alcohols: metabolized into toxic chemicals like aldehyde, organic acids, acetone", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Toxic alcohols: metabolized into toxic chemicals like aldehyde, organic acids, acetone"}
{"id": "article-30327_41", "title": "Deadly Single Dose Agents -- Function -- Toxicokinetics", "content": "Caustics/household products: direct mucosal and pulmonary damage (toxicity related to pH < 3 and > 13), methemoglobinemia (methacrylic acid), cyanide (a metabolite of acrylonitrile)", "contents": "Deadly Single Dose Agents -- Function -- Toxicokinetics. Caustics/household products: direct mucosal and pulmonary damage (toxicity related to pH < 3 and > 13), methemoglobinemia (methacrylic acid), cyanide (a metabolite of acrylonitrile)"}
{"id": "article-30327_42", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Alpha-2 adrenergic agonists: opioid toxidrome, altered mental status", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Alpha-2 adrenergic agonists: opioid toxidrome, altered mental status"}
{"id": "article-30327_43", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Sulfonylureas: anorexia, weakness, prolonged hypoglycemia up to 18\u00a0to 24 hours, lethargy, seizure, coma, headache, confusion, irritability", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Sulfonylureas: anorexia, weakness, prolonged hypoglycemia up to 18\u00a0to 24 hours, lethargy, seizure, coma, headache, confusion, irritability"}
{"id": "article-30327_44", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Calcium channel blockers: hyperglycemia, cardiovascular collapse, bradycardia, hypotension (verapamil and nifedipine worst) [7]", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Calcium channel blockers: hyperglycemia, cardiovascular collapse, bradycardia, hypotension (verapamil and nifedipine worst) [7]"}
{"id": "article-30327_45", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Beta-blockers: bradycardia and hypotension (generally not as severe in children), hypoglycemia, seizures, reflex tachycardia, 2nd- and 3rd-degree heart block, Torsades de pointes", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Beta-blockers: bradycardia and hypotension (generally not as severe in children), hypoglycemia, seizures, reflex tachycardia, 2nd- and 3rd-degree heart block, Torsades de pointes"}
{"id": "article-30327_46", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Tricyclic antidepressants: seizures, anticholinergic toxidrome, hypotension, metabolic acidosis, cardiac conduction abnormalities (QRS prolongation and prominent R in aVR, hypotension, CNS depression, tachycardia then torsades de pointes)", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Tricyclic antidepressants: seizures, anticholinergic toxidrome, hypotension, metabolic acidosis, cardiac conduction abnormalities (QRS prolongation and prominent R in aVR, hypotension, CNS depression, tachycardia then torsades de pointes)"}
{"id": "article-30327_47", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Opioids: hypoxic respiratory failure, miosis, CNS depression", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Opioids: hypoxic respiratory failure, miosis, CNS depression"}
{"id": "article-30327_48", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Anti-diarrheals: initially anticholinergic toxidrome then opioid toxidrome; cardiac dysrhythmias, ataxia, irritability, hypokalemia, myopathy, neuropathy, AMS, ocular toxicity, ototoxicity [8]", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Anti-diarrheals: initially anticholinergic toxidrome then opioid toxidrome; cardiac dysrhythmias, ataxia, irritability, hypokalemia, myopathy, neuropathy, AMS, ocular toxicity, ototoxicity [8]"}
{"id": "article-30327_49", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Salicylates/methyl salicylates: nausea and vomiting, diaphoresis, hyperthermia, tinnitus, CNS depression, hyperventilation, primary metabolic acidosis, pulmonary edema, cerebral edema, coma", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Salicylates/methyl salicylates: nausea and vomiting, diaphoresis, hyperthermia, tinnitus, CNS depression, hyperventilation, primary metabolic acidosis, pulmonary edema, cerebral edema, coma"}
{"id": "article-30327_50", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Antipsychotics: seizures, anticholinergic toxidrome, prolonged QTc, wide QRS, tachycardia, hypotension", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Antipsychotics: seizures, anticholinergic toxidrome, prolonged QTc, wide QRS, tachycardia, hypotension"}
{"id": "article-30327_51", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Antimalarials: delirium, coma, dysrhythmias, seizures, prolonged QT, widened QRS, hypotension, hypoglycemia, visual disturbances (blurry, diplopia, altered color perception)", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Antimalarials: delirium, coma, dysrhythmias, seizures, prolonged QT, widened QRS, hypotension, hypoglycemia, visual disturbances (blurry, diplopia, altered color perception)"}
{"id": "article-30327_52", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Antiarrhythmics: nausea and vomiting, hypotension, QRS widening, heart block, hyperthermia, hypoglycemia, bradycardia, tachyarrhythmias, ventricular tachycardia/fibrillation, torsades de pointes", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Antiarrhythmics: nausea and vomiting, hypotension, QRS widening, heart block, hyperthermia, hypoglycemia, bradycardia, tachyarrhythmias, ventricular tachycardia/fibrillation, torsades de pointes"}
{"id": "article-30327_53", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Terpenoid (camphor): respiratory suppression, status epilepticus, typical odor, GI distress, sense of warmth, CNS hyperactivity, then depression", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Terpenoid (camphor): respiratory suppression, status epilepticus, typical odor, GI distress, sense of warmth, CNS hyperactivity, then depression"}
{"id": "article-30327_54", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Non-alkaloid toxic lignan: GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Non-alkaloid toxic lignan: GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia"}
{"id": "article-30327_55", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Plant toxin/secondary metabolite: Same as lignan. GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia [9]", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Plant toxin/secondary metabolite: Same as lignan. GI symptoms, CNS changes (confusion, coma, delirium, hallucinations), pancytopenia [9]"}
{"id": "article-30327_56", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Oral acetylcholinesterase inhibitors: increased level and duration of neurotransmitters", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Oral acetylcholinesterase inhibitors: increased level and duration of neurotransmitters"}
{"id": "article-30327_57", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Methylxanthine: vomiting, anxiety, agitation, seizures, ventricular dysrhythmias, hypotension, tachycardia", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Methylxanthine: vomiting, anxiety, agitation, seizures, ventricular dysrhythmias, hypotension, tachycardia"}
{"id": "article-30327_58", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Partial opioid agonist/synthetics: opioid toxidrome, agitation [10]", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Partial opioid agonist/synthetics: opioid toxidrome, agitation [10]"}
{"id": "article-30327_59", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Toxic alcohols: confusion, vomiting, seizures, hypopnea, cyanosis, hypothermia, syncope", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Toxic alcohols: confusion, vomiting, seizures, hypopnea, cyanosis, hypothermia, syncope"}
{"id": "article-30327_60", "title": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG", "content": "Caustics/household products: drooling, perioral burns, respiratory distress, dysphagia, metabolic effects (methemoglobinemia, hemolysis, cyanide toxicity)", "contents": "Deadly Single Dose Agents -- Function -- Symptoms/Physical Findings/Labs/EKG. Caustics/household products: drooling, perioral burns, respiratory distress, dysphagia, metabolic effects (methemoglobinemia, hemolysis, cyanide toxicity)"}
{"id": "article-30327_61", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Alpha-2 adrenergic agonists: naloxone (antidote);\u00a0supportive care, airway protection, respiratory support, atropine, IV fluids, vasopressors", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Alpha-2 adrenergic agonists: naloxone (antidote);\u00a0supportive care, airway protection, respiratory support, atropine, IV fluids, vasopressors"}
{"id": "article-30327_62", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Sulfonylureas: octreotide (antidote); serial glucose monitoring, glucagon, GI decontamination, IV dextrose bolus (can overstimulate the pancreas and cause rebound hypoglycemia), 24-hour observation", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Sulfonylureas: octreotide (antidote); serial glucose monitoring, glucagon, GI decontamination, IV dextrose bolus (can overstimulate the pancreas and cause rebound hypoglycemia), 24-hour observation"}
{"id": "article-30327_63", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Calcium channel blockers: high dose Insulin/euglycemic therapy (antidote); other antidotes (weaker evidence) such as lipid emulsion, IV calcium, methylene blue (amlodipine), ECMO for cardiovascular collapse, atropine, cardiac pacing, pressors [11] [12]", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Calcium channel blockers: high dose Insulin/euglycemic therapy (antidote); other antidotes (weaker evidence) such as lipid emulsion, IV calcium, methylene blue (amlodipine), ECMO for cardiovascular collapse, atropine, cardiac pacing, pressors [11] [12]"}
{"id": "article-30327_64", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Beta-blockers: glucagon (antidote); monitoring, vasopressors, cardiac pacing, whole bowel irrigation, calcium", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Beta-blockers: glucagon (antidote); monitoring, vasopressors, cardiac pacing, whole bowel irrigation, calcium"}
{"id": "article-30327_65", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Tricyclic antidepressants: sodium bicarb/lipid emulsion (antidotes); aggressive ABCs, urine alkalinization, activated charcoal, benzodiazepines (may rapidly deteriorate)", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Tricyclic antidepressants: sodium bicarb/lipid emulsion (antidotes); aggressive ABCs, urine alkalinization, activated charcoal, benzodiazepines (may rapidly deteriorate)"}
{"id": "article-30327_66", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Opioids: naloxone (antidote); supportive care, airway protection, respiratory support, 24 hours observation for longer-acting opioids", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Opioids: naloxone (antidote); supportive care, airway protection, respiratory support, 24 hours observation for longer-acting opioids"}
{"id": "article-30327_67", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Anti-diarrheals: naloxone (antidote); fluids, airway support, supportive care", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Anti-diarrheals: naloxone (antidote); fluids, airway support, supportive care"}
{"id": "article-30327_68", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Salicylates/Methylsalicylates: sodium bicarbonate (antidote), urine alkalinization, supportive care, activated charcoal, dialysis. May require long observation (may not peak until 24 hours)", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Salicylates/Methylsalicylates: sodium bicarbonate (antidote), urine alkalinization, supportive care, activated charcoal, dialysis. May require long observation (may not peak until 24 hours)"}
{"id": "article-30327_69", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Antipsychotics: sodium bicarbonate\u00a0(antidote); supportive care, benzodiazepines, cardiac monitoring, GI decontamination", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Antipsychotics: sodium bicarbonate\u00a0(antidote); supportive care, benzodiazepines, cardiac monitoring, GI decontamination"}
{"id": "article-30327_70", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Antimalarials: sodium\u00a0bicarbonate\u00a0(antidote); ECMO, supportive care, benzodiazepines, cardiac monitoring, glucose (severe \u2013 epinephrine, intubation, gastric lavage)", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Antimalarials: sodium\u00a0bicarbonate\u00a0(antidote); ECMO, supportive care, benzodiazepines, cardiac monitoring, glucose (severe \u2013 epinephrine, intubation, gastric lavage)"}
{"id": "article-30327_71", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Antiarrhythmics: sodium\u00a0bicarbonate\u00a0(antidote); supportive care, cardiac monitoring, intravenous fluid bolus", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Antiarrhythmics: sodium\u00a0bicarbonate\u00a0(antidote); supportive care, cardiac monitoring, intravenous fluid bolus"}
{"id": "article-30327_72", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Terpenoid (camphor): supportive care; benzodiazepines, airway monitoring, remove chemical if possible", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Terpenoid (camphor): supportive care; benzodiazepines, airway monitoring, remove chemical if possible"}
{"id": "article-30327_73", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Non-alkaloid toxic lignan: supportive care; remove topicals, GI decontamination", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Non-alkaloid toxic lignan: supportive care; remove topicals, GI decontamination"}
{"id": "article-30327_74", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Plant toxin/secondary metabolite: supportive care; remove topicals, GI decontamination", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Plant toxin/secondary metabolite: supportive care; remove topicals, GI decontamination"}
{"id": "article-30327_75", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Oral acetylcholinesterase inhibitors:\u00a0atropine, 2-PAM (pralidoxime), and diazepam", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Oral acetylcholinesterase inhibitors:\u00a0atropine, 2-PAM (pralidoxime), and diazepam"}
{"id": "article-30327_76", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Methylxanthine: supportive care; IV fluids, benzodiazepines, antiemetics, activated charcoal, inotropes", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Methylxanthine: supportive care; IV fluids, benzodiazepines, antiemetics, activated charcoal, inotropes"}
{"id": "article-30327_77", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Partial opioid agonist/synthetics:\u00a0naloxone (antidote); supportive care, airway protection, respiratory support", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Partial opioid agonist/synthetics:\u00a0naloxone (antidote); supportive care, airway protection, respiratory support"}
{"id": "article-30327_78", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Toxic alcohols: ethanol, fomepizole (antidote); supportive care, specific treatment depends on the type of alcohol", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Toxic alcohols: ethanol, fomepizole (antidote); supportive care, specific treatment depends on the type of alcohol"}
{"id": "article-30327_79", "title": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first)", "content": "Caustics/household products: (multiple specific treatments) supportive care, airway protection, dilution, cyanide kit, methylene blue", "contents": "Deadly Single Dose Agents -- Issues of Concern -- Treatment/Management (currently recommended\u00a0antidotes listed first). Caustics/household products: (multiple specific treatments) supportive care, airway protection, dilution, cyanide kit, methylene blue"}
{"id": "article-30327_80", "title": "Deadly Single Dose Agents -- Clinical Significance", "content": "Although there is little primary research into poisonings, there are numerous case reports and summary articles on the topic.\u00a0Novel therapies are in development and testing all the time; for example, methylene blue in amlodipine overdose and \u201cold\u201d therapies such as ECMO are seeing more use and with greater success. [13] [14] In treating patients, be sure to liberally utilize the regional poison control center to ensure the use of the latest therapies and best management available. Toxicologists are always standing by to assist. Also, numerous web resources, such as UpToDate and eMedicine, and textbooks, such as Goldfrank, provide very specific\u00a0and current treatment protocols. Observation and supportive care are sufficient for most toxic ingestions, but some, like these highly dangerous substances, require specific treatment and a knowledgeable clinician.", "contents": "Deadly Single Dose Agents -- Clinical Significance. Although there is little primary research into poisonings, there are numerous case reports and summary articles on the topic.\u00a0Novel therapies are in development and testing all the time; for example, methylene blue in amlodipine overdose and \u201cold\u201d therapies such as ECMO are seeing more use and with greater success. [13] [14] In treating patients, be sure to liberally utilize the regional poison control center to ensure the use of the latest therapies and best management available. Toxicologists are always standing by to assist. Also, numerous web resources, such as UpToDate and eMedicine, and textbooks, such as Goldfrank, provide very specific\u00a0and current treatment protocols. Observation and supportive care are sufficient for most toxic ingestions, but some, like these highly dangerous substances, require specific treatment and a knowledgeable clinician."}
{"id": "article-30327_81", "title": "Deadly Single Dose Agents -- Enhancing Healthcare Team Outcomes", "content": "Although identification and proper management of toxic ingestions are vital skills for emergency and acute care clinicians, one cannot forget those that support our mission both before arrival and after treatment and discharge. \u00a0Caring for these complicated overdoses is a daunting task, especially for the pre-hospital personnel, as well as those providing aftercare. Numerous studies and articles are now focusing on reducing unnecessary ER visits for minor ingestions\u00a0and patient safety, and proper mental health or substance abuse referrals. [15] More evidence-based research is necessary on preventing recidivism, and more collaborative programs need to be developed to provide clear pathways to recovery for the patients\u00a0who have intentionally overdosed. As the U.S. opioid crisis has received federal attention (and funding to address it) - now is the time to capitalize on the national momentum to improve our comprehensive care of these patients. \u00a0Now is also the time to build our care teams when these patients present to the ER.\u00a0A collaboration of EMS, ED providers, clinical pharmacologists, poison control, intensivists, mental health providers, and addiction specialists is necessary for this patient's journey to full recovery.", "contents": "Deadly Single Dose Agents -- Enhancing Healthcare Team Outcomes. Although identification and proper management of toxic ingestions are vital skills for emergency and acute care clinicians, one cannot forget those that support our mission both before arrival and after treatment and discharge. \u00a0Caring for these complicated overdoses is a daunting task, especially for the pre-hospital personnel, as well as those providing aftercare. Numerous studies and articles are now focusing on reducing unnecessary ER visits for minor ingestions\u00a0and patient safety, and proper mental health or substance abuse referrals. [15] More evidence-based research is necessary on preventing recidivism, and more collaborative programs need to be developed to provide clear pathways to recovery for the patients\u00a0who have intentionally overdosed. As the U.S. opioid crisis has received federal attention (and funding to address it) - now is the time to capitalize on the national momentum to improve our comprehensive care of these patients. \u00a0Now is also the time to build our care teams when these patients present to the ER.\u00a0A collaboration of EMS, ED providers, clinical pharmacologists, poison control, intensivists, mental health providers, and addiction specialists is necessary for this patient's journey to full recovery."}
{"id": "article-30327_82", "title": "Deadly Single Dose Agents -- Enhancing Healthcare Team Outcomes", "content": "Due to the complexity and risk of patients exposed to these agents, an interprofessional team approach will lead to the best outcomes. The nurse should help the clinician obtain an accurate patient and family history, including making calls as necessary to family members and pharmacists. The specialty-trained toxicology pharmacist should evaluate drug-drug interactions, select antidotes, and provide guidance for care to the team. The clinician should consult a clinical toxicologist in most cases to assist in guiding evaluation and therapy. Often a mental health counselor is involved as well. Only by working together as a team will these patients obtain the best care and chance for long-term survival. [Level 5]", "contents": "Deadly Single Dose Agents -- Enhancing Healthcare Team Outcomes. Due to the complexity and risk of patients exposed to these agents, an interprofessional team approach will lead to the best outcomes. The nurse should help the clinician obtain an accurate patient and family history, including making calls as necessary to family members and pharmacists. The specialty-trained toxicology pharmacist should evaluate drug-drug interactions, select antidotes, and provide guidance for care to the team. The clinician should consult a clinical toxicologist in most cases to assist in guiding evaluation and therapy. Often a mental health counselor is involved as well. Only by working together as a team will these patients obtain the best care and chance for long-term survival. [Level 5]"}
{"id": "article-30327_83", "title": "Deadly Single Dose Agents -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Deadly Single Dose Agents -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}